Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2017

01-03-2017 | CE - COCHRANE'S CORNER

Open access to scientific articles: a review of benefits and challenges

Author: Bo-Christer Björk

Published in: Internal and Emergency Medicine | Issue 2/2017

Login to get access

Abstract

The Internet has fundamentally changed the publishing of scholarly peer reviewed journals, and the way readers find and access articles. Digital access is nowadays the norm, in particular for researchers. The Internet has enabled a totally new business model, Open Access (OA), in which an article is openly available in full text for anyone with Internet access. This article reviews the different options to achieve this, whether by journals changing their revenue structures from subscription to publishing charges, or authors utilizing a number of options for posting OA versions of article manuscripts in repositories. It also discusses the regrettable emergence of “predatory” publishers, who spam academics, and make money by promising them rapid publication with only the semblance of peer review. The situation is further discussed from the viewpoints of different stakeholders, including academics as authors and readers, practicing physicians and the general public.
Literature
2.
go back to reference Vinny P, Vishnu V (2016) Trends in scientific publishing: dark clouds loom large. J Neurol Sci 363:119–120CrossRefPubMed Vinny P, Vishnu V (2016) Trends in scientific publishing: dark clouds loom large. J Neurol Sci 363:119–120CrossRefPubMed
7.
go back to reference Houghton J, Rasmussen B, Sheehan P, Oppenheim C, Morris A, Creaser C, Greenwood H, Summers M, Gourlay A (2009) Economic implications of alternative scholarly publishing models: exploring the costs and benefits. Joint Information Systems Committee, UK. https://dspace.lboro.ac.uk/2134/4137. Accessed 20 Dec 2016 Houghton J, Rasmussen B, Sheehan P, Oppenheim C, Morris A, Creaser C, Greenwood H, Summers M, Gourlay A (2009) Economic implications of alternative scholarly publishing models: exploring the costs and benefits. Joint Information Systems Committee, UK. https://​dspace.​lboro.​ac.​uk/​2134/​4137. Accessed 20 Dec 2016
8.
go back to reference Schimmer R, Geschuhn K, Vogler A (2015) Disrupting the subscription journals’ business model for the necessary large-scale transformation to open access, Max Planck Digital Library, Munich. doi:10.17617/1.3 Schimmer R, Geschuhn K, Vogler A (2015) Disrupting the subscription journals’ business model for the necessary large-scale transformation to open access, Max Planck Digital Library, Munich. doi:10.17617/1.3
15.
go back to reference Laakso M (2015) Green open access policies of scholarly journal publishers: a study of what, when, and where self-archiving is allowed. Scientometrics 99:475–494CrossRef Laakso M (2015) Green open access policies of scholarly journal publishers: a study of what, when, and where self-archiving is allowed. Scientometrics 99:475–494CrossRef
20.
go back to reference Björk B-C (2016) The open access movement at a crossroads—are the big publishers and academic social media taking over? Learn Publish 29:131–134CrossRef Björk B-C (2016) The open access movement at a crossroads—are the big publishers and academic social media taking over? Learn Publish 29:131–134CrossRef
Metadata
Title
Open access to scientific articles: a review of benefits and challenges
Author
Bo-Christer Björk
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1603-2

Other articles of this Issue 2/2017

Internal and Emergency Medicine 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine